A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy Subjects
Clinical trial NCT03197779 · COMPLETED
Trial details
- NCT number
- NCT03197779
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-18
- Primary completion
- 2016-02-02
- Enrollment
- 691
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.